IPSEN - Buy-Back Programme - Art 5 Of MAR - Week 34 - 2025

2025-08-29 12:16:19

(MENAFN- GlobeNewsWire - Nasdaq) Aggregated presentation by day and by market
Statement of transactions in own shares from August 18 ^th to August 22 ^nd 2025

Name of the issuer	Identity code of the issuer (Legal Entity Identifier)	Day of the transaction	Identity code of the financial instrument	Total daily volume (in number of shares)	Daily weighted average purchase price of the shares	Market (MIC Code)
IPSEN	549300M6SGDPB4Z94P11	18/08/2025	FR0010259150	600	113	CCXE
IPSEN	549300M6SGDPB4Z94P11	18/08/2025	FR0010259150	300	112,9	TQEX
IPSEN	549300M6SGDPB4Z94P11	18/08/2025	FR0010259150	3 261	113,41791	XPAR
IPSEN	549300M6SGDPB4Z94P11	19/08/2025	FR0010259150	300	114,5	AQEU
IPSEN	549300M6SGDPB4Z94P11	19/08/2025	FR0010259150	1 200	114,6	CCXE
IPSEN	549300M6SGDPB4Z94P11	19/08/2025	FR0010259150	300	114,6	TQEX
IPSEN	549300M6SGDPB4Z94P11	19/08/2025	FR0010259150	3 292	114,177	XPAR
IPSEN	549300M6SGDPB4Z94P11	20/08/2025	FR0010259150	300	116,1	AQEU
IPSEN	549300M6SGDPB4Z94P11	20/08/2025	FR0010259150	600	115,05	CCXE
IPSEN	549300M6SGDPB4Z94P11	20/08/2025	FR0010259150	300	116,096	TQEX
IPSEN	549300M6SGDPB4Z94P11	20/08/2025	FR0010259150	3 600	115,56664	XPAR
IPSEN	549300M6SGDPB4Z94P11	21/08/2025	FR0010259150	600	115,46	AQEU
IPSEN	549300M6SGDPB4Z94P11	21/08/2025	FR0010259150	300	115,9	CCXE
IPSEN	549300M6SGDPB4Z94P11	21/08/2025	FR0010259150	600	115,5	TQEX
IPSEN	549300M6SGDPB4Z94P11	21/08/2025	FR0010259150	3 189	115,33801	XPAR
IPSEN	549300M6SGDPB4Z94P11	22/08/2025	FR0010259150	300	117,156	AQEU
IPSEN	549300M6SGDPB4Z94P11	22/08/2025	FR0010259150	1 300	116,92308	CCXE
IPSEN	549300M6SGDPB4Z94P11	22/08/2025	FR0010259150	300	116,8	TQEX
IPSEN	549300M6SGDPB4Z94P11	22/08/2025	FR0010259150	3 340	117,19009	XPAR
			TOTAL	23 982	115,2171

Attachment

EN_IPSEN - Buy-back programme - Art 5 of MAR - Week 34_2025 (1)

MENAFN29082025004107003653ID1109994039

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.